Year: 2026
Type: article
Study design: Case Report
Abstract: CaseA 56-year-old male with inoperable ischemic cardiomyopathy and severe nonspecific interstitial pneumonia underwent en bloc heart-lung transplantation in 2023 with induction via basiliximab 20 mg and methylprednisolone 1000 mg.His postoperative course was complicated by renal failure and physical debility.
Source: Transplant Infectious Disease
DOI: 10.1111/tid.70170
Institutions: Cedars-Sinai Medical Center, Emory University
Language: English
Subfield: Endocrinology
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W7124833362
